The Increase in Serum Soluble ST2 Protein Upon Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Chest

Volumn 124, Issue 4, 2003, Pages 1206-1214

  Tajima, Shunji ^a   Oshikawa, Katsuhisa ^a   Tominaga, Shin Ichi ^a   Sugiyama, Yukihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute exacerbation; Idiopathic pulmonary fibrosis; Proinflammatory cytokine; ST2; T helper type 2

Indexed keywords

C REACTIVE PROTEIN; LACTATE DEHYDROGENASE; OXYGEN; PROTEIN; PROTEIN ST 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INTERMETHOD COMPARISON; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ALVEOLUS OXYGEN TENSION; LUNG FIBROSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TH2 CELL; UNIVERSITY HOSPITAL; VITAL CAPACITY;

EID: 0142010561     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.4.1206     Document Type: Article

References (46)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161:646-664
2. Campbell DA, Poulter LW, Janossy G, et al. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 1985; 40:405-411
3. Haslam PL. Evaluation of alveolitis by studies of lung biopsies. Lung 1990; 168:984-992
4. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17:138-146
5. Wallace WA, Ramage EA, Lamb D, et al. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995; 101:436-441
6. Wallace WA, Howie SE. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease. J Pathol 1999; 187:475-480
7. Furuie H, Yamasaki H, Suga M, et al. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. Eur Respir J 1997; 10:787-794
8. Kohase M, May LT, Tamm I, et al. A cytokine network in human diploid fibroblasts: interactions of β-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol 1987; 7:273-280
9. Nash JR, McLaughlin PJ, Butcher D, et al. Expression of tumour necrosis factor-α in cryptogenic fibrosing alveolitis. Histopathology 1993; 22:343-734
10. Piguet PF, Ribaux C, Karpuz V, et al. Expression and localization of tumor necrosis factor-α and its mRNA in idiopathic pulmonary fibrosis. Am J Pathol 1993; 143:651-655
11. Zhang Y, Lee TC, Guillemin B, et al. Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993; 150:4188-4196
12. Tominaga S. A putative protein of a growth specific cDNA from BALB/C-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett 1989; 258:301-304
13. Yanagisawa K, Tsukamoto T, Takagi T, et al. Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Lett 1992; 302:51-53
14. Werenskiold AK, Hoffmann S, Klemenz R. Induction of a mitogen-responsive gene after expression of the Ha-ras oncogene in NIH 3T3 fibroblasts. Mol Cell Biol 1989; 9:5207-5214
15. Bergers G, Reikerstorfer A, Braselmann S, et al. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994; 13:1176-1188
16. Lanahan A, Williams JB, Sanders LK, et al. Growth factor-induced delayed early response genes. Mol Cell Biol 1992; 12:3919-3929
17. Tominaga S, Jenkins NA, Gilbert DJ, et al. Molecular cloning of the murine ST2 gene: characterization and chromosomal mapping. Biochim Biophys Acta 1991; 1090:1-8
18. Tominaga S, Inazawa J, Tsuji S. Assignment of the human ST2 gene to chromosome 2 at q11.2. Hum Genet 1996; 97:561-563
19. Dale M, Nicklin MJ. Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 1999; 57:177-179
20. Li H, Tago K, Io K, et al. The cloning and nucleotide sequence of human ST2L cDNA. Genomics 2000; 67:284-290
21. Yanagisawa K, Naito Y, Kuroiwa K, et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J Biochem (Tokyo) 1997; 121:95-103
22. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998; 187:787-794
23. Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A 1998; 95:6930-6935
24. Oshikawa K, Yanagisawa K, Ohno S, et al. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 2002; 165:1005-1009
25. Kuroiwa K, Li H, Tago K, et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma 2000; 19:151-159
26. Oshikawa K, Kuroiwa K, Tago K, et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001; 164:277-281
27. Kumar S, Tzimas MN, Griswold DE, et al. Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli. Biochem Biophys Res Commun 1997; 235:474-478
28. Pan LH, Ohtani H, Yamauchi K, et al. Co-expression of TNF-α and IL-1β in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 1996; 46:91-99
29. Akira M, Hamada H, Sakatani M, et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1997; 168:79-83
30. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest 1993; 103:1808-1812
31. Murray JF, Matthay MA, Luce JM, et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-723
32. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345:517-525
33. Kolb M, Margetts PJ, Anthony DC, et al. Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 2001; 107:1529-1536
34. Sime PJ, Marr RA, Gauldie D, et al. Transfer of tumor necrosis factor-α to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol 1998; 153:825-832
35. Pfeffer LM, Murphy JS, Tamm I. Interferon effects on the growth and division of human fibroblasts. Exp Cell Res 1979; 121:111-120
36. Duncan MR, Berman B. Gamma interferon is the lymphokine and β interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985; 162:516-527
37. Lawrence DA. Transforming growth factor-β: a general review. Eur Cytokine Netw 1996; 7:363-374
38. Gharaee-Kermani M, Nozaki Y, Hatano K, et al. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine 2001; 15:138-147
39. Keane MP, Belperio JA, Burdick MD, et al. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2001; 281:L92-L97
40. Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon-γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341:1264-1269
41. Oshikawa K, Kuroiwa K, Tokunaga T, et al. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respir Med 2001; 95:532-533
42. Oshikawa K, Yanagisawa K, Tominaga S, et al. ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation. Biochem Biophys Res Commun 2002; 299: 18-24
43. DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 1968; 204:1193-1195
44. Coyle AJ, Lloyd C, Tian J, et al. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med 1999; 190:895-902
45. Oshikawa K, Yanagisawa K, Tominaga S, et al. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 2002; 32:1520-1526
46. Sweet MJ, Leung BP, Kang D, et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 2001; 166:6633-6639